Skip to content

Antidepressant SSRI Birth Defects & Cranial Malformations

Selective seratonin reuptake inhibitor drugs are known as SSRI antidepressants. Serious side effects are linked to the following antidepressants when taken while pregnant: * Prozac®, *…

Selective seratonin reuptake inhibitor drugs are known as SSRI antidepressants.
Serious side effects are linked to the following antidepressants when taken while pregnant:

* Prozac®,     * Xanax®,     * Wellbutrin®,     * Paxil®

Children born with heart birth defects, lung birth defects and other  congenital birth defects have been linked to the possible use of a group  of antidepressant drugs classified as Selective Serotonin Re-uptake  Inhibitors (SSRI) by women during pregnancy.  In a medical study,  infants exposed to SSRI antidepressants during the first trimester of  pregnancy had a 60% higher probability of developing congenital heart  defects compared to newborns whose mothers did not take SSRI  antidepressants.

texas_ssri_birth_defect_attorney.jpg

According to the FDA, healthcare  professionals are advised to carefully weigh the potential risks and  benefits of using SSRI therapy in women during pregnancy and to discuss  these findings as well as treatment alternatives with their patients.

Additional research recently published in the New England Journal of  Medicine shows that use of anti-depressant medications during the latter  half of pregnancy increases the risk the newborn will develop a serious  respiratory disorder known as Persistent Pulmonary Hypertension (PPHN).   When a newborn suffers from Persistent Pulmonary Hypertension (PPHN),  the pulmonary arteries (blood vessels in the lungs) fail to fully open,  and the newborn is unable to oxygenate his/her blood. Without an  adequate supply of oxygen-rich blood, the infant can suffer serious  complications.

Data from this study indicate that the use of Selective Serotonin  Reuptake Inhibitors (SSRIs) such as Prozac®, Zoloft® and Paxil® during  the second half of pregnancy may increase the risk of Persistent  Pulmonary Hypertension (PPHN) by as much as six times the normal risk.

The anti-depressant drugs – known as Selective Serotonin Reuptake Inhibitors (SSRIs) include the following:

* Paxil® (paroxetine),     * Zoloft® (sertraline),     *  Wellbutrin® (bupropion),     * Celexa® (citalopram),     * Cipralex®  (escitalopram),     * Luvox® (fluvoxamine),     * Remeron®  (mirtazapine),     * Effexor® (venlafaxine),     * Prozac® (fluoxetine)

Shezad Malik MD JD

Shezad Malik MD JD

Shezad Malik is an Internal Medicine and Cardiology specialist, a Texas Medical Doctor (retired) and Defective Medical Device and Dangerous Drug Attorney.

All articles

More in FDA & Prescription Drugs

See all

Januvia Pancreatic Cancer Lawsuit

/

More from Shezad Malik MD JD

See all
Ozempic and Wegovy, Here’s the Skinny

Ozempic and Wegovy, Here’s the Skinny

/
Benzene Work Exposure leads to Blood Cancer

Benzene Work Exposure leads to Blood Cancer

/